Expertise in
18
conditions

Dr. Benjamin M. Greenberg

Neurology
University Of Texas Southwestern Medical Center
5323 Harry Hines Blvd, 
Dallas, TX 
Offers Telehealth
Expertise in
18
conditions
University Of Texas Southwestern Medical Center
5323 Harry Hines Blvd, 
Dallas, TX 

Overview

Benjamin Greenberg is a Neurologist practicing medicine in Dallas, Texas.

Dr. Greenberg is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Transverse Myelitis, Optic Neuritis, Neuromyelitis Optica, and Multiple Sclerosis (MS).

He is actively involved in clinical research, co-authoring 204 peer reviewed articles and participating in 9 clinical trials.

Specialties

Neurology

Licenses

Psychiatry & Neurology in MD

Hospital Affiliations

UT Of Texas Southwestern University Hospital - William P. Clements Jr.

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

University of Texas Southwestern Medical Center
5323 Harry Hines Blvd, Dallas, TX 75390

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Collaboration on Neuroimmunology: Question, Understand, Educate, Restore - The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
Collaboration on Neuroimmunology: Question, Understand, Educate, Restore - The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Phase 1 Intrathecal Lumbar Administration of AAV9/CLN7 for Treatment of CLN7 Disease
Phase 1 Intrathecal Lumbar Administration of AAV9/CLN7 for Treatment of CLN7 Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2025
Intervention Type: Genetic
Study Phase: Phase 1
A Phase 2, Open-Label, Sequential Group, Investigator Blinded Study of Magnetic Resonance Spectroscopy (31P-MRS) to Assess the Effects of CNM-Au8 for the Bioenergetic Improvement of Impaired Neuronal Redox State in Multiple Sclerosis.
A Phase 2, Open-Label, Sequential Group, Investigator Blinded Study of Magnetic Resonance Spectroscopy (31P-MRS) to Assess the Effects of CNM-Au8 for the Bioenergetic Improvement of Impaired Neuronal Redox State in Multiple Sclerosis.
Enrollment Status: Completed
Publish Date: December 19, 2025
Intervention Type: Drug
Study Drug: Gold Nanocrystals
Study Phase: Phase 2
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: ANK-700
Study Phase: Phase 1
PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.
PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.
Enrollment Status: Completed
Publish Date: September 05, 2023
Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study
Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study
Enrollment Status: Completed
Publish Date: August 23, 2022
Effect of MD1003 in Progressive Multiple Sclerosis: a Randomized Double Blind Placebo Controlled Study
Effect of MD1003 in Progressive Multiple Sclerosis: a Randomized Double Blind Placebo Controlled Study
Enrollment Status: Terminated
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 3
Integrative Examination of Neurobehavioral Mechanisms in Tic Suppression
Integrative Examination of Neurobehavioral Mechanisms in Tic Suppression
Enrollment Status: Completed
Publish Date: July 17, 2020
Intervention Type: Other
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis
Enrollment Status: Completed
Publish Date: October 18, 2018
View 8 Less Clinical Trials

204 Total Publications

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Journal: JAMA neurology
Published: July 13, 2026
Similar Doctors
Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
 (0.1 miles away)
214-645-4673
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Justin Jordan is a Neurologist practicing medicine in Dallas, Texas. He has been practicing medicine for over 17 years. Dr. Jordan is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 1 (NF1), Neurofibromatosis Type 2 (NF2), and Tissue Biopsy. Dr. Jordan is currently accepting new patients.

Expertise in
31
conditions
Expertise in
31
conditions
Referral required

James W. Aston Ambulatory Care Center

5303 Harry Hines Blvd., 8th Floor, 
Dallas, TX 
 (0.1 miles away)
214-645-8800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Steven Vernino is a Neurologist practicing medicine in Dallas, Texas. Dr. Vernino is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Familial Dysautonomia, Orthostatic Hypotension, Low Blood Pressure, Multiple System Atrophy, and Nerve Decompression. Dr. Vernino is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required
Before you request

Texas Scottish Rite Hospital For Children

2222 Welborn St, 
Dallas, TX 
 (1.6 miles away)
214-559-5000
Languages Spoken:
English, Hindi, Marathi
See accepted insurances
Accepting New Patients

Charuta Joshi is a Neurologist practicing medicine in Dallas, Texas. Dr. Joshi is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Epilepsy, Seizures, West Syndrome, Epilepsy in Children, and Deep Brain Stimulation. Dr. Joshi is board certified in Epilepsy- American Board Of Psychiatry And Neurology, Neurology With Special Qualification In Child Neurology- American Board Of Psychiatry And Neurology, Neurology With Special Qualification In Child Neurology- American Board Of Psychiatry And Neurology/Neurology With Special Qualification In Child Neurology, and Epilepsy- American Board Of Psychiatry And Neurology/Epilepsy. Dr. Joshi is currently accepting new patients.

Frequently Asked Questions about Dr. Benjamin M. Greenberg

How do I make an appointment with Dr. Benjamin M. Greenberg?

You can book an appointment with Dr. Benjamin M. Greenberg by calling their office at 214-645-8800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Benjamin M. Greenberg a top-rated expert for Transverse Myelitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Benjamin M. Greenberg is classified as an Elite expert for Transverse Myelitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Benjamin M. Greenberg specialize in?

While Dr. Benjamin M. Greenberg is a Neurology, they have specific expertise in Transverse Myelitis, Optic Neuritis, and Neuromyelitis Optica. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Benjamin M. Greenberg participate in research or clinical trials?

Yes. Dr. Benjamin M. Greenberg has published 204 articles and abstracts on conditions like Transverse Myelitis. You can view a list of Dr. Benjamin M. Greenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Benjamin M. Greenberg accept my insurance?

Dr. Benjamin M. Greenberg accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 214-645-8800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Greenberg's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 7 Advanced Conditions
View All 30 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile